Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir for HIV-related hyperlipidemia
NCT00887653Phase 3Completed
- Sponsor
- The Miriam Hospital
- Start
- May 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir in hyperlipidemia, hypertriglyceridemia, sponsored by The Miriam Hospital. Started May 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
hyperlipidemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT00887653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887653.